Fellowships, Gifts, and Supported Research
Targeted Ex vivo Nanotherapy for use in Cardiac Transplantation ·
2017
- 2019
Primary Investigator ·
American Heart Association
· $110,456.00
17CPOST3367120. Utilized micellar rapamycin nanoparticles targeted to coronary endothelium during static cold storage to ameliorate ischemia-reperfusion injury post transplantation.
Amelioration of Cardiac Transplant Vasculopathy Using Targeted Ex Vivo Nanotherapy ·
2015
- 2017
T32 Postdoctoral Fellow ·
National Institute of Health; National Heart, Lung, and Blood Institute
· $100,000.00
NIH-HL-007260. Utilized micellar rapamycin nanoparticles targeted to coronary endothelium during static cold storage to delay the onset of chronic rejection and cardiac allograft vasculopathy.